STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
St. Jude Children's Research Hospital
Abramson Cancer Center at Penn Medicine
Adela, Inc
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
AVM Biotechnology Inc
Washington University School of Medicine
Trishula Therapeutics, Inc.
Tempus AI
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
University Health Network, Toronto
Massachusetts General Hospital
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Zhejiang Provincial People's Hospital
Cedars-Sinai Medical Center
Celldex Therapeutics
OHSU Knight Cancer Institute
Corvus Pharmaceuticals, Inc.
Biologics & Biosimilars Collective Intelligence Consortium
Fate Therapeutics
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Hospital Universitario San Ignacio
Weprom
Hospices Civils de Lyon
AstraZeneca
First Affiliated Hospital of Wenzhou Medical University
National Cancer Institute (NCI)
Tocagen Inc.
Shenzhen BinDeBio Ltd.
Tel-Aviv Sourasky Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
sigma-tau i.f.r. S.p.A.
Incyte Corporation
Celgene
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Stanford University
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alberta
National Institutes of Health Clinical Center (CC)